Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vognus M 500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Aminus Remedies

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview Vognus M 500mg/0.2mg Tablet SR

Diabexe Duo 500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adult patients. It helps regulate blood glucose levels. Diabexe Duo should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices are integral to diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes; these are usually transient and self-limiting. Persistent or concerning side effects warrant medical consultation. Your doctor can offer management strategies for any bothersome side effects. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Vognus M 500mg/0.2mg Tablet SR

No text provided to rephrase.

Uses of Vognus M 500mg/0.2mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Vognus M 500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vognus M 500mg/0.2mg Tablet SR whole; do not fracture, pulverize, or chew. Administer this extended-release tablet with a meal.

Common Side effects of Vognus M 500mg/0.2mg Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Vognus M 500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vognus M 500mg/0.2mg Tablet SR whole; do not fracture, pulverize, or chew. Administer this extended-release tablet with a meal.

How Vognus M 500mg/0.2mg Tablet SR works:

Vognus M 500mg/0.2mg sustained-release tablets contain a dual antidiabetic drug formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Vognus M 500mg/0.2mg Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Vognus M 500mg/0.2mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Vognus M 500mg/0.2mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Vognus M 500mg/0.2mg Tablet SR. Nevertheless, patients taking this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Exercise caution when administering Vognus M 500mg/0.2mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Vognus M 500mg/0.2mg Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Vognus M 500mg/0.2mg sustained-release tablets in individuals with hepatic impairment. Seek medical advice.

What if you forget to take Vognus M 500mg/0.2mg Tablet SR :

Should you forget a Vognus M 500mg/0.2mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vognus M 500mg/0.2mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes
Vognus M 500mg/0.2mg Tabl...
44
MRP 54
18% off